Predicting TERT promoter mutation status using 1 H-MR spectroscopy and stretched-exponential model of diffusion-weighted imaging in IDH -wildtype diffuse astrocytic glioma without intense enhancement

Purpose Isocitrate dehydrogenase (IDH )-wildtype diffuse astrocytic glioma with telomerase reverse transcriptase ( TERT ) promoter mutation is defined as glioblastoma by the WHO 2021 criteria, revealing that TERT promotor mutation is highly associated with tumor aggressiveness. The aim of this study was to identify features from MR spectroscopy (MRS) and multi-exponential models of DWI distinguishing wild-type TERT ( TERTw ) from TERT promoter mutation ( TERTm ) in IDH -wildtype diffuse astrocytic glioma. Methods Participants comprised 25 adult patients with IDH -wildtype diffuse astrocytic glioma. Participants were classified into TERTw and TERTm groups. Point-resolved spectroscopy sequences were used for MRS data acquisition. DWI was performed with 13 different b-factors. Peak height ratios of NAA/Cr and Cho/Cr were calculated from MRS data. Mean apparent diffusion coefficient (ADC), perfusion fraction ( f ), diffusion coefficient (D), pseudo-diffusion coefficient (D*), distributed diffusion coefficient (DDC), and heterogeneity index (α) were obtained using multi-exponential models from DWI data. Each parameter was compared between TERTw and TERTm using the Mann–Whitney U test. Correlations between parameters derived from MRS and DWI were also evaluated. Results NAA/Cr and Cho/Cr were both higher for TERTw than for TERTm . The α of TERTw was smaller than that of TERTm , while the f of TERTw was higher than that of TERTm . NAA/Cr correlated negatively with α, but not with other DWI parameters. Cho/Cr did not show significant correlations with any DWI parameters. Conclusion The combination of NAA/Cr and α may have merit in clinical situation to predict the TERT mutation status of IDH -wildtype diffuse astrocytic glioma without intense enhancement.